NCT04475185终止不适用
Interventional, Open, Non-comparative, Multicenter Study to Assess the Safety and Effectiveness of the Use of the MakAir Artificial Ventilator in the Expected Situation of a Shortage of Technical Devices for Invasive Mechanical Ventilation, Linked to the Coronavirus COVID-19
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 4
- 试验地点
- 4
- 主要终点
- Number of dysfunctions
研究概览
简要总结
The objective of our study is to carry out an evaluation of the safety and the effectiveness of the use of the MakAir respirator as useful supplement in situation of shortage of technical devices of assistance to the mechanical invasive ventilation, related to COVID-19 through a protocol in 3 successive sequences.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Sequential
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Sequence 1 :
- •Patient for whom a certificate has been signed by a support person / family member / close relative independent of the sponsor.
- •Non-hypoxemic patient (PaO2 / FiO2> 300)
- •Patient requiring invasive mechanical ventilation> 24 hours
- •Stabilized patient, i.e. not needing an increase in oxygenation for at least 6 hours
- •Sequence 2 :
- •Patient for whom a certificate of consent has been signed by a support person / family member / close relative independent of the sponsor.
- •Patient with mild to moderate Acute respiratory distress syndrome (300> Pa02 / FiO2> 100)
- •Patient requiring invasive mechanical ventilation> 3 days
- •Stabilized patient, i.e. having not required an increase in oxygenation for at least 6 hours
- •Sequence3 :
- •Patient for whom a certificate of consent has been signed by a support person / family member / close relative independent of the sponsor or waiver due to life-threatening emergency.
- •Patient with mild to moderate Acute respiratory distress syndrome (PaO2 / FiO2> 100) or without Acute respiratory distress syndrome
- •Patient requiring invasive mechanical ventilation for any duration
- •Situation of shortage among centers investigating technical devices for invasive ventilation to treat all patients
排除标准
- •Sequence 1 and sequence 2:
- •Patient positive or showing signs of Covid-19 infection
- •Tracheotomized patient
- •History of pulmonary emphysema or severe to moderate chronic obstructive pulmonary disease
- •Patient in recovery and withdrawal phase of ventilatory assistance
- •Pneumothorax or pneumomediastinum
- •Hemodynamic instability
- •Intracranial hypertension
- •Pregnant woman (A urine or blood pregnancy test must be performed for women of childbearing age)
- •Major protected (guardianship, curatorship and under the protection of justice)
- •Lack of affiliation to the French social security system
- •Participation in another interventional clinical trial
- •Sequence3 :
- •Tracheotomized patient
- •History of pulmonary emphysema or severe to moderate moderate chronic obstructive pulmonary disease
- •Patient in recovery and withdrawal phase of ventilatory assistance
- •Pneumothorax or pneumomediastinum
- •Hemodynamic instability
- •Intracranial hypertension
- •Pregnant woman (A urine or blood pregnancy test must be performed for women of childbearing age)
- •Major protected (guardianship, curatorship and under the protection of justice)
- •Lack of affiliation to the French social security system
- •Participation in another interventional clinical trial on mechanical ventilation
结局指标
主要结局
Number of dysfunctions
时间窗: 10 days for sequence 3
Number of dysfunctions which can lead to or have led to "respiratory" adverse events or to serious adverse events (SAE)
次要结局
未报告次要终点
研究者
研究点 (4)
Loading locations...
相似试验
Unknown
不适用
Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.Diabetes Mellitus, Type 2NCT04326166Dong-A ST Co., Ltd.1,971
已完成
不适用
Performance and Efficacy of the CardiacSense1 for Detection of Atrial FibrillationFibrillation AtriumNCT03477734CardiacSense Ltd.53
Approved For Marketing
不适用
Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid ArthritisRheumatoid ArthritisNCT00649545Abbott
招募中
不适用
LANDMARK Trial: a Randomised Controlled Trial of Myval THVAortic Valve StenosisNCT04275726Meril Life Sciences Pvt. Ltd.988
撤回
2 期
Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral SclerosisALSNCT03457753Aquestive Therapeutics